c neoformans (ATCC)

ATCC is a verified supplier

ATCC manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

ATCC c neoformans
C Neoformans, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/22790/Ascoidea+hylecoeti+Batra+et+Francke-Grosmann/us12042514-374-103-127
Average 90 stars, based on 4 article reviews

c neoformans - by Bioz Stars, 2026-10

90/100 stars

Images

Virus:

Article Title: Anticandida Activity Is Retained in P-113, a 12-Amino-Acid Fragment of Histatin 5
Article Snippet: .. Importantly, the susceptibilities of C. albicans strains to either amphotericin B or fluconazole was not altered in LYM broth compared to those in RPMI 1640 medium (data not shown). table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Organism Origin a Identification code P-113 MIC (μg/ml) Candida albicans ATCC 10231 3.1 Candida albicans ATCC 44505 3.1 Candida albicans HIV pt. isolate 443 3.1 Candida albicans HIV pt. isolate 84 3.1 Candida albicans HIV pt. isolate 111 3.1 Candida albicans HIV pt. isolate 206 3.1 Candida albicans b HIV pt. isolate 207 3.1 Candida albicans b HIV pt. isolate 78 1.6 Candida albicans b HIV pt. isolate 20 3.1 Candida albicans HIV pt. isolate 118 3.1 Candida albicans HIV pt. isolate 269 3.1 Candida albicans HIV pt. isolate 162 3.1 Candida albicans HIV pt. isolate 359 3.1 Candida albicans b HIV pt. isolate 575 3.1 Candida albicans HIV pt. isolate 52 3.1 Candida albicans HIV pt. isolate 125 3.1 Candida albicans HIV pt. isolate 209 3.1 Candida albicans HIV pt. isolate 123 3.1 Candida albicans HIV pt. isolate 508 3.1 Candida albicans HIV pt. isolate 283 3.1 Candida albicans b HIV pt. isolate 5 3.1 Candida glabrata ATCC 98-2229 1.6 Candida glabrata Clinical isolate 98-2237 1.6 Candida glabrata Clinical isolate 98-2267 1.6 Candida glabrata Clinical isolate 98-2272 1.6 Candida glabrata Clinical isolate 98-2255 1.6 Candida glabrata Clinical isolate 98-2279 0.8 Candida glabrata Clinical isolate 98-2282 1.6 Candida glabrata Clinical isolate 98-2314 3.1 Candida glabrata Clinical isolate 98-2320 1.6 Candida glabrata Clinical isolate 98-2332 3.1 Candida krusei ATCC 14243 1.6 Candida kefyr ATCC 66028 6.3 Candida parapsilosis Clinical isolate 98-2318 3.1 Candida parapsilosis Clinical isolate 98-2305 3.1 Candida parapsilosis Clinical isolate 98-2297 3.1 Candida tropicalis Clinical isolate 98-2327 1.6 Candida tropicalis Clinical isolate 98-2323 3.1 Candida tropicalis Clinical isolate 98-2091 1.6 Open in a separate window a ATCC, American Type Culture Collection (Manassas, Va.); HIV pt. isolate, isolate from a human immunodeficiency virus-infected patient. b C. albicans strains resistant to fluconazole (MICs, >50 μg/ml). ..

Article Title: Anticandida Activity Is Retained in P-113, a 12-Amino-Acid Fragment of Histatin 5
Article Snippet: .. Antifungal activity of P-113 Organism Origina Identificationcode P-113 MIC (mg/ml) Candida albicans ATCC 10231 3.1 Candida albicans ATCC 44505 3.1 Candida albicans HIV pt. isolate 443 3.1 Candida albicans HIV pt. isolate 84 3.1 Candida albicans HIV pt. isolate 111 3.1 Candida albicans HIV pt. isolate 206 3.1 Candida albicansb HIV pt. isolate 207 3.1 Candida albicansb HIV pt. isolate 78 1.6 Candida albicansb HIV pt. isolate 20 3.1 Candida albicans HIV pt. isolate 118 3.1 Candida albicans HIV pt. isolate 269 3.1 Candida albicans HIV pt. isolate 162 3.1 Candida albicans HIV pt. isolate 359 3.1 Candida albicansb HIV pt. isolate 575 3.1 Candida albicans HIV pt. isolate 52 3.1 Candida albicans HIV pt. isolate 125 3.1 Candida albicans HIV pt. isolate 209 3.1 Candida albicans HIV pt. isolate 123 3.1 Candida albicans HIV pt. isolate 508 3.1 Candida albicans HIV pt. isolate 283 3.1 Candida albicansb HIV pt. isolate 5 3.1 Candida glabrata ATCC 98-2229 1.6 Candida glabrata Clinical isolate 98-2237 1.6 Candida glabrata Clinical isolate 98-2267 1.6 Candida glabrata Clinical isolate 98-2272 1.6 Candida glabrata Clinical isolate 98-2255 1.6 Candida glabrata Clinical isolate 98-2279 0.8 Candida glabrata Clinical isolate 98-2282 1.6 Candida glabrata Clinical isolate 98-2314 3.1 Candida glabrata Clinical isolate 98-2320 1.6 Candida glabrata Clinical isolate 98-2332 3.1 Candida krusei ATCC 14243 1.6 Candida kefyr ATCC 66028 6.3 Candida parapsilosis Clinical isolate 98-2318 3.1 Candida parapsilosis Clinical isolate 98-2305 3.1 Candida parapsilosis Clinical isolate 98-2297 3.1 Candida tropicalis Clinical isolate 98-2327 1.6 Candida tropicalis Clinical isolate 98-2323 3.1 Candida tropicalis Clinical isolate 98-2091 1.6 a ATCC, American Type Culture Collection (Manassas, Va.); HIV pt. isolate, isolate from a human immunodeficiency virus-infected patient. b C. albicans strains resistant to fluconazole (MICs, .50 mg/ml). on S eptem ber 1, 2014 by U niv of Idaho http://aac.asm .org/ D ow nloaded from characteristic of polypeptide random coils. ..

Activity Assay:

Bacteria:

Article Title: Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
Article Snippet: .. TABLE 7 Efficacy of Sulfuric Acid Composition vs Common Bacterial and Fungal Respiratory Pathogens pH As pH As Efficacy Efficacy Pathogen Received Applied Log % 43 K. pneumoniae 1.871 1.987 5.22 >99.99% 44 K. pneumoniae 2.163 2.279 0.88 86.97% 45 H. influenzae 1.871 1.987 >6.94 >99.9999% 46 H. influenzae 2.163 2.279 >6.94 >99.9999% 47 M. terrae 1.871 1.987 0.12 24.56% 48 M. terrae 2.163 2.279 0.02 5.56% 49 A. fumigatus 1.871 1.987 1.66 97.83% 50 A. fumigatus 2.163 2.279 1.7 98.00% 51 R. microsporus 1.871 1.987 1.73 98.13% 52 R. microsporus 2.163 2.279 1.73 98.13% 53 C. neoformans 1.871 1.987 0.03 6.43% 54 C. neoformans 2.163 2.279 0.04 9.36% Test conditions: Tested In Accordance With ASTM E2315, 1 minute, no soiling, non-GLP, single-replicant Bacteria tested: Klebsiella pneumoniae ATCC 4532, Haemophilus influenza ATCC 8149, Mycobacterium terrae ATCC 15755 Fungi tested: Aspergillus fumigatus ATCC 36607, Rhizopus microspores ATCC 52807, Cryptococcous neoformans ATCC 66031 Conclusions: It is noted that 1.99 pH sulfuric acid is highly effective against both Klebsiella pneumoniae and Haemophilus influenza. ..

Expressing:

Article Title: A profile of 8-oxo-dGTPase activities in the NCI-60 human cancer panel: Meta-analytic insight into the regulation and role of MTH1 (NUDT1) gene expression in carcinogenesis.
Article Snippet: .. For this purpose all available MTH1 z-scores (12 in most cases) for the 59 cell lines have been averaged, giving the following integrated MTH1 expression z-scores: CCRF-CEM: 2.9893, HL-60(TB): 0.8178, K-562: -0.7434, MOLT-4: -0.2775, RPMI-8226: -0.1419, SR: 0.2248, A549/ATCC: 0.2715, EKVX: 0.2858, HOP-62: -0.6308, HOP-92: -0.1013, NCI-H226: -0.6528, NCI-H23: 1.9629, NCI-H322M: 1.4084, NCI-H460: 0.0792, NCI-H522: -0.2483, COLO205: 0.6650, HCC-2998: -0.0060, HCT-116: -0.7296, HCT-15: -0.9233, HT29: -0.3817, KM12: -0.3473, SW-620: -0.2189, SF-268: 0.5170, SF-295: 0.8383, SF-539: 0.5031, SNB-19: 0.8208, SNB-75: -0.4071, U251: 2.2282, LOXIMVI: -0.1532, MALME-3M: 0.4383, M14: -0.2538, MDA-MB-435: -0.5973, SK-MEL-2: 0.1932, SK-MEL-28: 0.2586, SK-MEL-5: 0.9284, UACC-257: -0.1012, UACC-62: -0.1453, IGROV1: -0.2279, OVCAR-3: -0.7268, OVCAR-4: -0.6395, OVCAR-5: -0.4953, OVCAR-8: -0.7403, NCI/ADR-RES: -0.5704, SK-OV-3: -1.0567, 786-0: -0.1274, A498: 0.2676, ACHN: -0.1841, CAKI-1: -0.7590, RXF393: 0.5003, SN12C: -0.0680, TK-10: -0.8080, UO-31: -0.5808, PC-3: -0.7493, DU-145: -0.5330, MCF7: 0.6019, MDA-MB-231/ATCC: -0.5648, HS578T: -0.3195, BT-549: -0.1946, T-47D: -0.2739. .. As Figure 6 makes clear, the individual MTH1 profiles are highly correlated with the integrated one and the calculated Pearson correlation coefficients are much higher than their respective MPCC values (Agilent: r = 0.926, p = 8.5e-26; Genelogic U95: r = 0.903, p = 1.3e-22; Novartis U95: r = 0.869, p = 4.6e-19; U133 Plus 2.0: r = 0.867, p = 6.8e-19; HuEx 1.0 ST exon 4: r = 0.842, p = 1.3e-16; Genelogic U133: r = 0.789, p = 1.1e-13; Applied Genomics: r = 0.777, p = 1.9e-12; Chiron U133: r = 0.729, p = 9.0e-11; 8-oxo-dGTPase activity: r = 0.725, p = 8.4e-11; IDIS: r = 0.636; p = 8.3e-8; Millennium: r = 0.630, p = 9.1e-8; BI Hu6800: r = 0.617, p = 2.0e-7).

Multiple Displacement Amplification:

Inhibition:

Article Title: Phytochemical composition, anti-biofilm and anti-quorum sensing potential of fruit, stem and leaves of Salvadora persica L. methanolic extracts.
Article Snippet: Accepted Manuscript Phytochemical composition, anti-biofilm and anti-quorum sensing potential of fruit, stem and leaves of Salvadora persica L. methanolic extracts Emira Noumi, Mejdi Snoussi, Abderrahmen Merghni, Filomena Nazzaro, Guillermo Quindós, Gültekin Akdamar, Maha Mastouri, Abdulbasset Al-Sieni, Ozgur Ceylan PII: S0882-4010(17)30397-2 DOI: 10.1016/j.micpath.2017.05.036 Reference: YMPAT 2280 To appear in: Microbial Pathogenesis Received Date: 11 April 2017 Revised Date: 20 May 2017 Accepted Date: 23 May 2017 Please cite this article as: Noumi E, Snoussi M, Merghni A, Nazzaro F, Quindós G, Akdamar Gü, Mastouri M, Al-Sieni A, Ceylan O, Phytochemical composition, anti-biofilm and anti-quorum sensing potential of fruit, stem and leaves of Salvadora persica L. methanolic extracts, Microbial Pathogenesis (2017), doi: 10.1016/j.micpath.2017.05.036.. This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.

Review

c neoformans (ATCC)

Structured Review

Images

Related Articles

Virus:

Activity Assay:

Bacteria:

Expressing:

Multiple Displacement Amplification:

Inhibition:

Concentration Assay:

Similar Products

Image Search Results